Liquidia (LQDA) Income from Continuing Operations (2020 - 2026)

Liquidia (LQDA) recorded quarterly Income from Continuing Operations of 52882000.0 in Q1 2026, up 263.33% quarter-over-quarter from 14555000.0 in Q4 2025, and up 237.83% on a YoY basis from 15653342.91 in Q1 2025.

Liquidia (LQDA) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Liquidia's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 52882000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 237.83% year-over-year to 52882000.0; the TTM figure through Mar 2026 stood at 22325000.0 (up 116.35% YoY), while the FY2025 annual figure was 68924000.0, up 46.28% from the prior year.
  • Income from Continuing Operations was 52882000.0 for Q1 2026 at Liquidia, up from 14555000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 52882000.0 in Q1 2026 to a low of 41579000.0 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 15326000.0 across 5 years, with a median of 15790000.0 in 2023.
  • The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations slumped 320.17% in 2023, then jumped 237.83% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 6533000.0 in 2022, then plunged by 320.17% to 27450000.0 in 2023, then tumbled by 40.29% to 38510000.0 in 2024, then jumped by 137.8% to 14555000.0 in 2025, then soared by 263.33% to 52882000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 52882000.0 (Q1 2026), 14555000.0 (Q4 2025), and 3533000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 52.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.88 Mn
Dec 31, 2025 14.56 Mn
Sep 30, 2025 -3.53 Mn
Jun 30, 2025 -41.58 Mn
Mar 31, 2025 -38.37 Mn
Dec 31, 2024 -38.51 Mn
Sep 30, 2024 -31.03 Mn
Jun 30, 2024 -28.67 Mn
Mar 31, 2024 -30.08 Mn
Dec 31, 2023 -27.45 Mn
Sep 30, 2023 -15.79 Mn
Jun 30, 2023 -23.52 Mn
Mar 31, 2023 -9.43 Mn
Dec 31, 2022 -6.53 Mn
Sep 30, 2022 -9.09 Mn
Jun 30, 2022 -9.45 Mn
Mar 31, 2022 -14.95 Mn
Dec 31, 2021 -11.56 Mn
Sep 30, 2021 -7.28 Mn
Jun 30, 2021 -6.55 Mn